Swiss Paraplegic Centre Nottwil - Recruiting 18 years to 90 years. - Clinical Value of Homeopathic Assessment and Treatment for Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury.
individual homeopathic treatment; standard treatment without homeopathy
StemCells, Inc. - Recruiting 18 years to 60 years. - A Phase I/II Study of the Safety and Preliminary Efficacy of Intramedullary Spinal Cord Transplantation of Human Central Nervous System (CNS) Stem Cells (HuCNS-SCr) in Subjects With Thoracic (T2-T11) Spinal Cord Trauma.
Brigham and Women's Hospital - Recruiting 18 years to 65 years. - A Phase IIa, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study Evaluating the Safety, Tolerability and Efficacy of V158866 in Central Neuropathic Pain Following Spinal Cord Injury.
Asubio Pharmaceuticals, Inc. - Recruiting 16 years to 80 years. - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury.
University of Zurich - Recruiting 18 years to 55 years. - The Bladder and the Brain - Investigation of the Supraspinal Neural Control of Lower Urinary Tract Function in Healthy Subjects and Patients With Neurogenic and Non-neurogenic Bladder Dysfunction Using Advanced Neuroimaging Techniques.